You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Pai Holdings Pharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PAI HOLDINGS PHARM, and what generic and branded alternatives to PAI HOLDINGS PHARM drugs are available?

PAI HOLDINGS PHARM has forty-four approved drugs.

Summary for Pai Holdings Pharm

US Patents:	0
Tradenames:	36
Ingredients:	31
NDAs:	44

Drugs and US Patents for Pai Holdings Pharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pai Holdings Pharm	FORTAZ	ceftazidime	INJECTABLE;INJECTION	050578-003	Jul 19, 1985		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Pai Holdings Pharm	FORTAZ	ceftazidime	INJECTABLE;INJECTION	050578-002	Jul 19, 1985		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Pai Holdings Pharm	FLUOCINONIDE	fluocinonide	CREAM;TOPICAL	211758-001	Apr 3, 2019		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Pai Holdings Pharm	NORFLEX	orphenadrine citrate	INJECTABLE;INJECTION	013055-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Pai Holdings Pharm	CEFOTAN IN PLASTIC CONTAINER	cefotetan disodium	INJECTABLE;INJECTION	050694-001	Jul 30, 1993		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Pai Holdings Pharm	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	088786-001	Sep 11, 1984		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Pai Holdings Pharm

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-001	Dec 17, 1986	4,585,790*PED	⤷ Subscribe
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,128,659	⤷ Subscribe
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-001	Dec 17, 1986	4,521,431*PED	⤷ Subscribe
Pai Holdings Pharm	ZANTAC	ranitidine hydrochloride	INJECTABLE;INJECTION	019090-001	Oct 19, 1984	4,128,658	⤷ Subscribe
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,585,790*PED	⤷ Subscribe
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,521,431*PED	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.